Form D · Other Health Care
Enhance Skin Products Inc
Toronto, A6 · CIK 0001395400
Offering snapshot reported Jun 18, 2015 · SEC filing
- Reported sold
- Yet to sell Indefinite offering
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 18, 2015 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| May 2, 2013 | Initial | $16,000 | No comparison | 1 | SEC filing |
| Sep 2, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Aug 28, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity, Debt, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-242068
Source: Form D, filed Jun 18, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Samuel Asculai | Director, Executive |
| Frode Botnevik | Director |
| Christopher Hovey | Director |
| Donald Nicholson | Director, Executive |
| Zenas Noon | Director |
| Drasko Puseljic | Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
1 Yonge Street Suite 1801
Toronto, A6, M5E 1W7
Toronto, A6, M5E 1W7